- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mo | VITURA HEALTH LIMITED: Amended Constitution - Late Lodgement | - | ASX | ||
| Mo | VITURA HEALTH LIMITED: Notification of cessation of securities - VIT | - | ASX | ||
| 23.12.25 | VITURA HEALTH LIMITED: Change of Director's Interest Notice - Late Lodgement | 1 | ASX | ||
| 17.12.25 | VITURA HEALTH LIMITED: Change of Company Secretary | - | ASX | ||
| VITURA HEALTH Aktie jetzt für 0€ handeln | |||||
| 01.12.25 | VITURA HEALTH LIMITED: Industry Advisory Group Charter | 2 | ASX | ||
| 26.11.25 | VITURA HEALTH LIMITED: Results of 2025 Annual General Meeting | 1 | ASX | ||
| 25.11.25 | VITURA HEALTH LIMITED: 2025 AGM presentation | - | ASX | ||
| 25.11.25 | VITURA HEALTH LIMITED: Withdrawal of resolution | 1 | ASX | ||
| 28.10.25 | VITURA HEALTH LIMITED: Ceasing to be a substantial holder | - | ASX | ||
| 27.10.25 | VITURA HEALTH LIMITED: Resignation of CFO and Company Secretary | 2 | ASX | ||
| 22.10.25 | VITURA HEALTH LIMITED: Notice of 2025 Annual General Meeting | - | ASX | ||
| 22.10.25 | VITURA HEALTH LIMITED: 2025 Annual Report | - | ASX | ||
| 01.10.25 | VITURA HEALTH LIMITED: Application for quotation of securities - VIT | 1 | ASX | ||
| 25.09.25 | VITURA HEALTH LIMITED: Update - Dividend/Distribution - VIT | - | ASX | ||
| 25.09.25 | VITURA HEALTH LIMITED: DRP allocation price | - | ASX | ||
| 24.09.25 | VITURA HEALTH LIMITED: Date for 2025 AGM | - | ASX | ||
| 09.09.25 | VITURA HEALTH LIMITED: Becoming a substantial holder | - | ASX | ||
| 09.09.25 | VITURA HEALTH LIMITED: Change in substantial holding | - | ASX | ||
| 05.09.25 | Dividendenbekanntmachungen (05.09.2025) | 13.157 | wallstreetONLINE (Dividenden) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) AAON INC US0003602069 0,1 USD 0,0858 EUR ACUSHNET HOLDINGS CORP US0050981085 0,235 USD 0,2017 EUR AIA GROUP LTD HK0000069689 0... ► Artikel lesen | |
| 27.08.25 | VITURA HEALTH LIMITED: Investor Webinar and presentation | - | ASX |
1 2 Weiter >>
33 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| AURORA CANNABIS | 3,670 | +0,41 % | Cannabis-Aktien im Abverkauf: Böses Omen für 2026? Anleger in Alarmstimmung bei Tilray, Canopy, Aurora & Co. | © Foto: adobe.stock.comMit dem Börsenjahr 2025 geht für den Cannabis-Sektor einmal mehr ein Jahr voller Herausforderungen zu Ende. Das Vertrauen von Anlegern und Investoren ist noch nicht zurück. Der... ► Artikel lesen | |
| TILRAY BRANDS | 8,101 | +0,04 % | Tilray stock forms a risky pattern: Jan. 8 will be key | ||
| ORGANIGRAM GLOBAL | 1,530 | +5,52 % | Organigram Global Inc: Organigram increases Phylos loan by $3-million (U.S.) | ||
| SNDL | 1,448 | -1,03 % | 1CM Inc.: SNDL & 1CM Provide Update Regarding Arrangement | Edmonton, Alberta and Toronto, Ontario--(Newsfile Corp. - December 15, 2025) - SNDL Inc. (NASDAQ: SNDL) (CSE: SNDL) ("SNDL") and 1CM Inc. (CSE: EPIC) (OTCQB: MILFF) (FSE: IQ70) ("1CM") announce... ► Artikel lesen | |
| MYDECINE INNOVATIONS GROUP | 0,117 | -0,43 % | XFRA NEW INSTRUMENTS AVAILABLE ON 22.10.2025 | The following instruments on XETRA do have their first trading 22.10.2025 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 22.10.2025
Aktien
1 KYG8827C1006 Malibu Life Holdings... ► Artikel lesen | |
| BIONANO GENOMICS | 1,590 | 0,00 % | Bionano Genomics: Bionano Reports Third Quarter 2025 Results and Highlights Recent Business Progress | SAN DIEGO, Nov. 13, 2025 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today reported financial results for the third quarter ended September 30, 2025. "Over the last year, we have taken... ► Artikel lesen | |
| TONIX PHARMACEUTICALS | 13,400 | +3,08 % | Tonix Pharmaceuticals Holding Corp.: Tonix Pharmaceuticals Announces Program Updates on Phase 2/3-Ready Long-Acting Monoclonal Antibody (mAb) Designed for Seasonal Prevention of Lyme Disease (TNX-4800) | Exploring clinical development plan options including a controlled human infection model (CHIM) and a Phase 2/3 adaptive field study Expect to have investigational product of TNX-4800 (anti-Borrelia... ► Artikel lesen | |
| HIGH TIDE | 2,375 | +0,42 % | High Tide, Village Farms, Bioxyne: Cannabis-Aktien als Profiteure der Trump-Regulierungswende? | ||
| ACHIEVE LIFE SCIENCES | 4,290 | -3,16 % | New Report Calls Achieve Life's Cytisinicline Best Therapy To Quit Smoking | ||
| JAGUAR HEALTH | 1,020 | +2,26 % | Jaguar Health, Inc.: Jaguar Health Awarded $240,000 FDA Grant in Support of Canalevia-CA1 for Treatment of Chemotherapy-Induced Diarrhea in Dogs | SAN FRANCISCO, CALIFORNIA / ACCESS Newswire / January 2, 2026 / Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar") today announced that it received notice from the U.S. Food and Drug Administration's Center... ► Artikel lesen | |
| MEDIPHARM LABS | 0,037 | +3,95 % | MediPharm Labs Corp.: MediPharm Labs Announces Board of Directors Changes: Shelley Potts Steps Down, Michael Bumby Returns | TORONTO, Dec. 10, 2025 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm" or the "Company"), a pharmaceutical company specialized in precision-based cannabinoids... ► Artikel lesen | |
| ARGENT BIOPHARMA | 0,030 | +3,45 % | Argent BioPharma Ltd.: Argent is Growing Through M&A: Projected Merged Company Value of $100M in AC8 Asset Acquisition | Acquisition Expands Clinical Pipeline, Strengthens IP Portfolio, and Grows EU Presence
Highlights
Binding term sheet signed to acquire key assets and IP of AusCann... ► Artikel lesen | |
| AUSCANN | - | - | Argent BioPharma Signs $15m Deal to Acquire Key Clinical and IP Assets from AusCann | ||
| AYR WELLNESS | 0,010 | 0,00 % | Ayr Wellness Inc.: AYR Wellness Announces Leadership Update | MIAMI, Dec. 30, 2025 (GLOBE NEWSWIRE) -- AYR Wellness Inc. (CSE: AYR.A, OTCQX: AYRWF) ("AYR" or the "Company"), a leading vertically integrated U.S. multi-state cannabis operator, announces that Donna... ► Artikel lesen |
Das Unternehmen VITURA HEALTH LIMITED kann der Branche Pharma zugeordnet werden. Der aktuelle Kurs liegt bei 0,029 Euro und damit -3,39 % im Minus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu VITURA HEALTH LIMITED finden Sie auf Wallstreet Online.